We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HAE market cap is 3.63B. The company's latest EPS is USD 3.4906 and P/E is 21.64.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 343.29M | 336.17M | 345.51M | 348.54M | 330.6M |
| Operating Income | 27.94M | 39.76M | 51.7M | 44.93M | 50.61M |
| Net Income | 20.37M | 38.37M | 33.83M | 37.49M | 57.98M |
| Year End March 28 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 903.28M | 1B | 1.17B | 1.31B | 1.36B |
| Operating Income | 90.78M | 81.33M | 155.65M | 162.88M | 187M |
| Net Income | 79.47M | 43.38M | 115.4M | 117.56M | 167.68M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.2B | 2.54B | 2.53B | 2.53B | 2.45B |
| Total Liabilities | 1.24B | 1.64B | 1.65B | 1.62B | 1.63B |
| Total Equity | 959.96M | 905.37M | 878.85M | 906.86M | 820.84M |
| Year End March 28 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.82B | 1.86B | 1.93B | 2.2B | 2.45B |
| Total Liabilities | 1.09B | 1.11B | 1.12B | 1.24B | 1.63B |
| Total Equity | 731.67M | 749.42M | 818M | 959.96M | 820.84M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 181.75M | -27.42M | 21.4M | 65.17M | 181.73M |
| Investing | -322.39M | -139.2M | -162.56M | -179.94M | -161.9M |
| Financing | 38.16M | 333.69M | 258.89M | 260.27M | 108.82M |
| Year End March 28 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 108.81M | 172.26M | 273.06M | 181.75M | 181.73M |
| Investing | -425.44M | -86.35M | -143.79M | -322.39M | -161.9M |
| Financing | 367.45M | -15.75M | -100.36M | 38.16M | 108.82M |
| Market Cap | 3.63B |
| Price to Earnings Ratio | 21.64 |
| Price to Sales Ratio | 2.67 |
| Price to Cash Ratio | 11.83 |
| Price to Book Ratio | 4.42 |
| Dividend Yield | - |
| Shares Outstanding | 48.04M |
| Average Volume (1 week) | 617.65k |
| Average Volume (1 Month) | 561.73k |
| 52 Week Change | -14.04% |
| 52 Week High | 94.985 |
| 52 Week Low | 55.23 |
| Spread (Intraday) | 52.97 (63.44%) |
| Company Name | Haemonetics Corp |
| Address |
155 federal street boston, massachusetts 02110 |
| Website | https://www.haemonetics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
